• Info
  • Significant Ownership

Significant Ownership of Flagship V VentureLabs Rx Fund, L.P.

Signature - Title
/s/ Noubar B. Afeyan, Ph.D. - Noubar B. Afeyan, Ph.D., Manager of General Partner
Location
Cambridge, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Flagship V VentureLabs Rx Fund, L.P..

Notify me when Flagship V VentureLabs Rx Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Flagship V VentureLabs Rx Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMGAQ OMEGA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 53% $1,461,279 -$336,554 29,225,579 0% Noubar Afeyan 03 Feb 2025

Schedules 13D/G Reported by Flagship V VentureLabs Rx Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.